Literature DB >> 26621153

Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.

Cornelia Lerner1, Silke Wemmert2, Florian Bochen2, Philipp Kulas2, Maximilian Linxweiler2, Andrea Hasenfus3, Joana Heinzelmann4, Petra Leidinger5, Christina Backes5, Eckart Meese5, Steffi Urbschat6, Bernhard Schick2.   

Abstract

PURPOSE: Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignancies worldwide with an unchanged 5-year survival rate during the last decade. To detect reliable prognostic markers and improve patients' outcome in future, the aim of our study was to detect differences in microRNA (miRNA; miR) expression profile and further on to analyze the functional role of selected miRNAs.
METHODS: Blood samples from HNSCC patients and sex- and age-matched healthy volunteers were analyzed by microarrays and validated by quantitative real-time PCR. Data were compared with tumor tissue results and all findings were correlated with clinical parameters. Additionally, the proliferation and migration potential of two cell lines transfected with miRNA mimics and inhibitors for miR-146a and miR-155 were examined.
RESULTS: Initial analysis of blood samples showed no significant differences between the miRNA profile of HNSCC patients and healthy controls (p > 0.05). Interestingly, down-regulation of miR-146a and miR-155 in blood of patients correlated with the occurrence of distant metastasis regarding tumor patients only (p = 0.023 and p = 0.028, respectively). Additionally, our investigations in tissue samples revealed a lower expression of miR-155 in tumor cells (p = 0.003) and a correlation with higher cT-classification for down-regulation of miR-146a (p = 0.005). Moreover, functional assays demonstrated that inhibition of miR-146a and miR-155 promoted dramatically proliferation and migration potential, whereas transfection of both mimics had an inhibitory effect.
CONCLUSIONS: Characterizing the expression of miR-146a and miR-155 and their functional role in tumor biology underlined significantly their proliferation and migration potential suggesting relevance as potential prognostic markers in HNSCC.

Entities:  

Keywords:  Blood; Head and neck squamous cell carcinoma; Metastasis; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26621153     DOI: 10.1007/s00432-015-2087-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  52 in total

Review 1.  Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

Authors:  Nobuyoshi Kosaka; Haruhisa Iguchi; Takahiro Ochiya
Journal:  Cancer Sci       Date:  2010-07-07       Impact factor: 6.716

2.  miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.

Authors:  Shu-Chun Lin; Chung-Ji Liu; Jung-An Lin; Wei-Fan Chiang; Pei-Shih Hung; Kuo-Wei Chang
Journal:  Oral Oncol       Date:  2010-02-06       Impact factor: 5.337

3.  A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma.

Authors:  Ge Gao; Hiram A Gay; Rebecca D Chernock; Tian R Zhang; Jingqin Luo; Wade L Thorstad; James S Lewis; Xiaowei Wang
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

4.  MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.

Authors:  Zhibo Hou; Li Xie; Lixia Yu; Xiaoping Qian; Baorui Liu
Journal:  Med Oncol       Date:  2011-02-24       Impact factor: 3.064

5.  microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.

Authors:  Zhibo Hou; Haitao Yin; Cong Chen; Xinzheng Dai; Xiaolin Li; Baorui Liu; Xuefeng Fang
Journal:  Mol Med Rep       Date:  2012-06-13       Impact factor: 2.952

6.  MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Authors:  L Scapoli; A Palmieri; L Lo Muzio; F Pezzetti; C Rubini; A Girardi; F Farinella; M Mazzotta; F Carinci
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

7.  MicroRNA expression profiles in head and neck cancer cell lines.

Authors:  Nham Tran; Tessa McLean; Xiaoying Zhang; Chuan Jia Zhao; John Michael Thomson; Christopher O'Brien; Barbara Rose
Journal:  Biochem Biophys Res Commun       Date:  2007-04-09       Impact factor: 3.575

8.  Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1.

Authors:  Guoying Lao; Ping Liu; Qiongwei Wu; Wenying Zhang; Yu Liu; Longtao Yang; Chengbin Ma
Journal:  Tumour Biol       Date:  2014-08-26

9.  What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.

Authors:  Petra Leidinger; Christina Backes; Indra N Dahmke; Valentina Galata; Hanno Huwer; Ingo Stehle; Robert Bals; Andreas Keller; Eckart Meese
Journal:  Oncotarget       Date:  2014-10-15

10.  Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study.

Authors:  C B Lajer; F C Nielsen; L Friis-Hansen; B Norrild; R Borup; E Garnæs; M Rossing; L Specht; M H Therkildsen; B Nauntofte; S Dabelsteen; C von Buchwald
Journal:  Br J Cancer       Date:  2011-02-15       Impact factor: 7.640

View more
  12 in total

1.  miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2.

Authors:  Cong Wang; Wenxue Zhang; Lin Zhang; Xuan Chen; Fang Liu; Jing Zhang; Shanghui Guan; Yi Sun; Pengxiang Chen; Ding Wang; Effat Un Nesa; Yufeng Cheng; George M Yousef
Journal:  Br J Cancer       Date:  2016-11-10       Impact factor: 7.640

2.  Comparison of the miRNA expression profiles in fresh frozen and formalin-fixed paraffin-embedded tonsillar tumors.

Authors:  Zuzana Vojtechova; Jiri Zavadil; Jan Klozar; Marek Grega; Ruth Tachezy
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

3.  MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case-control studies.

Authors:  Zhaolan Xiang; Jue Song; Xianlu Zhuo; Qi Li; Xueyuan Zhang
Journal:  Oncotarget       Date:  2017-01-03

4.  miR-146a promotes growth of osteosarcoma cells by targeting ZNRF3/GSK-3β/β-catenin signaling pathway.

Authors:  Chun Zhou; Chang-Qing Jiang; Zhen Zong; Jia-Chen Lin; Li-Feng Lao
Journal:  Oncotarget       Date:  2017-07-19

5.  Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis.

Authors:  Mei-Wei Li; Li Gao; Yi-Wu Dang; Ping Li; Zu-Yun Li; Gang Chen; Dian-Zhong Luo
Journal:  Cancer Cell Int       Date:  2019-06-24       Impact factor: 5.722

Review 6.  Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact.

Authors:  Takashi Takeuchi; Hiromichi Kawasaki; Amalia Luce; Alessia Maria Cossu; Gabriella Misso; Marianna Scrima; Marco Bocchetti; Filippo Ricciardiello; Michele Caraglia; Silvia Zappavigna
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

7.  Pentapartite fractionation of particles in oral fluids by differential centrifugation.

Authors:  Chiho Hiraga; Satoshi Yamamoto; Sadamitsu Hashimoto; Masataka Kasahara; Tamiko Minamisawa; Sachiko Matsumura; Akira Katakura; Yasutomo Yajima; Takeshi Nomura; Kiyotaka Shiba
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

8.  lncRNA HOXA11-AS Promotes Proliferation and Migration via Sponging miR-155 in Hypopharyngeal Squamous Cell Carcinoma.

Authors:  Jianing Xu; Qiyu Bo; Xiang Zhang; Dapeng Lei; Jue Wang; Xinliang Pan
Journal:  Oncol Res       Date:  2020-01-27       Impact factor: 5.574

Review 9.  Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts.

Authors:  Li-Jie Li; Wei-Min Chang; Michael Hsiao
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27

10.  miR-146a Inhibits Proliferation and Enhances Chemosensitivity in Epithelial Ovarian Cancer via Reduction of SOD2.

Authors:  YaJie Cui; Kai'e She; Defu Tian; Peilian Zhang; Xiaoyan Xin
Journal:  Oncol Res       Date:  2016       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.